Cargando…
Stability of erythropoietin repackaging in polypropylene syringes for clinical use
Introduction: Epoetin alfa (Eprex®) is a subcutaneous, injectable formulation of short half-life recombinant human erythropoietin (rHuEPO). To current knowledge there are no published studies regarding the stability of rHuEPO once repackaging occurs (r-EPO) for clinical trial purposes. Materials and...
Autores principales: | Marsili, Angela, Puorro, Giorgia, Pane, Chiara, de Rosa, Anna, Defazio, Giovanni, Casali, Carlo, Cittadini, Antonio, de Michele, Giuseppe, Florio, Brunello Ettore, Filla, Alessandro, Saccà, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355549/ https://www.ncbi.nlm.nih.gov/pubmed/28344481 http://dx.doi.org/10.1016/j.jsps.2016.01.003 |
Ejemplares similares
-
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201)
por: Pane, Chiara, et al.
Publicado: (2023) -
Vial-splitting and Repackaging into Aliquot-specific Syringes: A Cost-effective and Waste-decreasing Strategy for Sugammadex
por: Amaya, Sebastian, et al.
Publicado: (2023) -
A Combined Nucleic Acid and Protein Analysis in Friedreich Ataxia: Implications for Diagnosis, Pathogenesis and Clinical Trial Design
por: Saccà, Francesco, et al.
Publicado: (2011) -
The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration
por: Juhong, Jakkrit, et al.
Publicado: (2022) -
Stability of commercial parenteral lipid emulsions repacking to polypropylene syringes
por: Watrobska-Swietlikowska, Dorota
Publicado: (2019)